Format

Send to

Choose Destination
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S14-6. doi: 10.1016/S1472-9792(12)70006-9.

Creativity in tuberculosis research and discovery.

Author information

1
Division of Mycobacterial Research, MRC National Institute for Medical Research, London, UK. d.young@imperial.ac.uk

Abstract

The remarkable advances in TB vaccinology over the last decade have been driven by a pragmatic approach to moving candidates along the development pipeline to clinical trials, fuelled by encouraging data on protection in animal models. Efficacy data from Phase IIb trials of the first generation of new candidates are anticipated over the next 1-2 years. As outlined in the TB Vaccines Strategic Blueprint, to exploit this information and to inspire design of next generation candidates, it is important that this empirical approach is complemented by progress in understanding of fundamental immune mechanisms and improved translational modalities. Current trends towards improved experimental and computational approaches for studying biological complexity will be an important element in the developing science of TB vaccinology.

PMID:
22441152
DOI:
10.1016/S1472-9792(12)70006-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center